Literature DB >> 12561062

Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer.

David W Petrik1, David R McCready, Carol A Sawka, Vivek Goel.   

Abstract

BACKGROUND AND OBJECTIVES: Axillary lymph node dissection (ALND) in patients with breast cancer is crucial for accurate staging, provides excellent regional tumor control, and is included in the standard of care for the surgical treatment of breast cancer. However, the extent of ALND varies, and the extent of dissection and the number of lymph nodes that comprise an optimal axillary dissection are under debate. Despite conflicting evidence, several studies have shown that improved survival is correlated with more lymph nodes removed in both node-negative and node-positive patients. The purpose of this study is to determine which patient, tumor, surgeon, and hospital characteristics are associated with the number of nodes excised in early breast cancer patients.
METHODS: A random sample of 938 women with node-negative breast cancer was drawn from the Ontario Cancer Registry and the data supplemented with chart reviews. The extent of axillary dissection was studied by examining the number of nodes examined in relation to the patient, tumor, surgeon, and hospital factors.
RESULTS: The mean number of lymph nodes excised was 9.8 (SD = 4.8; range, 1-31), and 49% of patients had >/=10 nodes excised. Lower patient age was associated with the excision of more lymph nodes (>/=10 nodes: 63% of patients <40 years vs. 38% of patients >/=80 years). Surgeon academic affiliation and surgery in a teaching hospital were highly correlated with each other and were significantly associated with the excision of >/=10 nodes. The number of nodes excised was not associated with any tumor factors, nor with the breast operation performed. These results were confirmed with multivariable models.
CONCLUSIONS: Even though the number of lymph nodes found in the pathologic specimen can be influenced by factors other than surgical technique (e.g., number of nodes present, specimen handling, and pathologic examination), this study shows significant variation of this variable and an association with several patient and surgeon/hospital factors. This variation and the association with survival warrant further study and effort at greater consistency. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12561062     DOI: 10.1002/jso.10198

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  8 in total

1.  Lymph node ratio is more valuable than level III involvement for prediction of outcome in node-positive breast carcinoma patients.

Authors:  Emin Yildirim; Ugur Berberoglu
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

2.  A population-based comparison of adenocarcinoma of the large and small intestine: insights into a rare disease.

Authors:  Michael J Overman; Chung-Yuan Hu; Scott Kopetz; James L Abbruzzese; Robert A Wolff; George J Chang
Journal:  Ann Surg Oncol       Date:  2011-12-21       Impact factor: 5.344

3.  Surgical approach and the use of lymphadenectomy and adrenalectomy among patients undergoing radical nephrectomy for renal cell carcinoma.

Authors:  Christopher P Filson; David C Miller; Joanne S Colt; Julie Ruterbusch; W Marston Linehan; Wong-Ho Chow; Kendra Schwartz
Journal:  Urol Oncol       Date:  2011-03-17       Impact factor: 3.498

4.  Lymph node ratio may be supplementary to TNM nodal classification in node-positive breast carcinoma based on the results of 2,151 patients.

Authors:  Nüvit Duraker; Bakir Bati; Zeynep Civelek Çaynak; Davut Demir
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

5.  Surgeon characteristics and use of breast conservation surgery in women with early stage breast cancer.

Authors:  Dawn L Hershman; Donna Buono; Judith S Jacobson; Russell B McBride; Wei Yann Tsai; Kathie Ann Joseph; Alfred I Neugut
Journal:  Ann Surg       Date:  2009-05       Impact factor: 12.969

6.  Cancer survival in Ontario, 1986-2003: evidence of equitable advances across most diverse urban and rural places.

Authors:  Kevin M Gorey; Karen Y Fung; Isaac N Luginaah; Emma Bartfay; Caroline Hamm; Frances C Wright; Madhan Balagurusamy; Aziz Mohammad; Eric J Holowaty; Kathy X Tang
Journal:  Can J Public Health       Date:  2008 Jan-Feb

7.  Prognostic Significance of the Number of Removed and Metastatic Lymph Nodes and Lymph Node Ratio in Breast Carcinoma Patients with 1-3 Axillary Lymph Node(s) Metastasis.

Authors:  Nüvit Duraker; Bakır Batı; Davut Demir; Zeynep Civelek Caynak
Journal:  ISRN Oncol       Date:  2011-10-12

8.  Neoadjuvant chemotherapy in breast cancer significantly reduces number of yielded lymph nodes by axillary dissection.

Authors:  Thalia Erbes; Marzenna Orlowska-Volk; Axel Zur Hausen; Gerta Rücker; Sebastian Mayer; Matthias Voigt; Juliane Farthmann; Severine Iborra; Marc Hirschfeld; Philipp T Meyer; Gerald Gitsch; Elmar Stickeler
Journal:  BMC Cancer       Date:  2014-01-03       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.